| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |